(Q24296238)

1

0 references

X H Wei

2

0 references

Y P Pan

3

0 references

H C Li

4

0 references

H Yang

5

0 references

Q H He

6

0 references

Y Pang

7

0 references

Y Shan

8

0 references

F X Xiong

9

0 references

G Z Shao

10

0 references

R L Zhou

Mechanisms of cancer drug resistance

11

0 references

language of work or name

English

0 references

publication date

28 October 2010

0 references

published in

Oncogene

0 references

volume

29

0 references

issue

43

0 references

page(s)

5785-95

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Differential gene expression in pituitary adenomas by oligonucleotide array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.303